Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells-Reference-Cited by-同舟云学术

Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells

Published:1999-02 Issue:2 Volume:27 Page:259-265
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Bai Amuguleng,Kojima Hiroshi,Hori Mitsuo,Nara Nobuo,Komeno Takuya,Hasegawa Yuichi,Ninomiya Haruhiko,Abe Tsukasa,Nagasawa Toshiro

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference20 articles.

1. Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture;Miyauchi;Blood,1989

2. Different sensitivity of normal and leukemic progenitor cells to Ara-C and IL-3 combined treatment;Lista;Br J Haematol,1990

3. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation;te Boekhorst;Leukemia,1993

4. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro;Tafuri;Leukemia,1990

5. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia;Yamada;Leukemia,1995

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review;International Journal of Hematology;2023-06-03

2. Priming with GM-CSF instead of G-CSF enhances CAG-induced apoptosis of acute monocytic leukemia cells in vitro;Cancer Chemotherapy and Pharmacology;2019-05-21

3. Efficacy of high-dose cytarabine and aclarubicin in combination with G-CSF regimen compared to intermediate/high-dose cytarabine and standard-dose cytarabine induction regimen for non-remission acute myeloid leukemia;Indian Journal of Cancer;2019

4. HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants;PLOS ONE;2016-10-05

5. Granulocyte colony-stimulating factor inhibits CXCR4/SDF-1α signaling and overcomes stromal-mediated drug resistance in the HL-60 cell line;Experimental and Therapeutic Medicine;2016-04-20